Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine effects on inhibitory pain mechanisms in chronic pain patients
NL-OMON28485Not yet recruiting
- Sponsor
- TREND Community
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ketamine in Complex Regional Pain Syndrome Type 1 (CRPS-1), small fiber neuropathy (SFN) and fibromyalgia (FM), sponsored by TREND Community. Planned start Jan 2009; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)small fiber neuropathy (SFN)fibromyalgia (FM)
Beyond the preview
Go deeper on NL-OMON28485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28485.